Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium

被引:0
作者
Elena Ioana Braicu
Toon Van Gorp
Mani Nassir
Rolf Richter
Radoslav Chekerov
Khayal Gasimli
Dirk Timmerman
Ignace Vergote
Jalid Sehouli
机构
[1] Charité Medical University Berlin,Department of Gynecology, Campus Virchow Clinic
[2] Maastricht University Medical Centre,Department of Obstetrics and Gynecology
[3] University Hospital KU Leuven,Department of Obstetrics and Gynecology
来源
Journal of Ovarian Research | / 7卷
关键词
HE4; CA125; ROMA; Borderline ovarian tumors; Invasive implants;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 293 条
[1]  
Denkert C(2005)Borderline tumors of the ovary and peritoneal implants Verh Dtsch Ges Pathol 89 84-91
[2]  
Dietel M(2009)North Eastern Society of Gynecological Oncology (NOGGO). Clinical management of borderline tumors of the ovary: results of a multicentre survey of 323 clinics in Germany BR J Cancer 100 1731-1738
[3]  
Coumbos A(2012)Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome Gynecol Oncol 127 516-524
[4]  
Sehouli J(2009)Borderline tumors of the Ovary – A Systematic Review Geburtsh Frauenheilk 69 807-833
[5]  
Chekerov R(2012)Management and prognosis of borderline ovarian Brenner tumors Int J Gynecol Cancer 22 1332-1336
[6]  
Schadel D(2004)Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis Cancer 100 1045-1052
[7]  
Oskay-Oezcelik G(2006)Clinical outcome and risk factors for recurrence in borderline ovarian tumours Br J Cancer 94 1586-1591
[8]  
Lichtenegger W(2008)Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer Int J Cancer 123 1897-1901
[9]  
Kuehn W(2000)Surgery for borderline tumor of the ovary Semin Surg Oncol 19 69-75
[10]  
Avril S(1993)A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities Cancer 71 1810-20